News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
WCG has added two new hires to its electronic clinical outcomes assessment (eCOA) arm, MedAvante-ProPhase.
Steven Herne (image left), who joins MedAvante-ProPhase as the company’s chief commercial officer told us:
“I am excited to be part of an amazing executive leadership team with many leading experts in the clinical trial space that have solved, and will continue to interface to solve, unmet medical needs and advance key treatments necessary in certain therapeutic areas.
The commercial effort will continue to be laser focused to ensure innovation and technology are at the forefront of all direct conversations with our customers. MedAvante-ProPhase is poised and ready to commit to that customer journey.”
Michael Cioffi, MedAvante-ProPhase’s new senior vice president of clinical operations, also expressed his excitement to join the team and contribute his experience.
“I’m excited to join the team at MedAvante-ProPhase and contribute my experience to build a best-in-class delivery approach, that coupled with expert science and cutting-edge technology, will help define MedAvante-ProPhase as the leading provider of eCOA and clinician services,” he told us.